Table 3.

Relative odds of developing hypertension from prehypertension over five years by serum uric acid quartile

			Crude			Adjusted
Women	N	Cumulative incidence	OR	95% C.I.	p	OR	95% C.I.	p
1st quartile (<4.0 mg/dL)	354	16.7%	Reference			Reference
2nd quartile (4.0≤ <4.6 mg/dL)	386	21.5%	1.370	0.946–1.983	0.096	1.342	0.907–1.998	0.14
3rd quartile (4.6≤ <5.2 mg/dL)	359	26.2%	1.774	1.231–2.556	0.002	1.661	1.120–2.462	0.012
4th quartile (5.2≤ mg/dL)	404	32.4%	2.399	1.693–3.400	<0.001	1.970	1.338–2.901	<0.001
Men
1st quartile (<5.6 mg/dL)	550	24.4%	Reference			Reference
2nd quartile (5.6≤ <6.4 mg/dL)	534	25.3%	1.050	0.797–1.384	0.73	1.086	0.811–1.454	0.85
3rd quartile (6.4≤ <7.2 mg/dL)	504	24.4%	1.002	0.756–1.328	0.99	0.970	0.715–1.316	0.85
4th quartile (7.2≤ mg/dL)	493	30.2%	1.345	1.023–1.768	0.034	1.369	1.008–1.859	0.044

N, number of subjects; OR, odds ratio; p, probability

^*Data adjusted for age, body mass index, smoking and drinking habits, baseline systolic and diastolic blood pressure, pulse rate, diabetes mellitus, dyslipidemia, chronic kidney disease, and serum uric acid quartile.